Recently Viewed

You have no recently viewed item.

Recently Viewed

You have no recently viewed item.

Renodapt-S 360 Tablet

Current price is: ₹350.00. Original price was: ₹1,279.00.

You saved ₹929.00 (73%)

Brand Name: Renodapt
Category: Transplant
Manufacturer: Biocon Biologics Ltd
Composition: Mycophenolate Sodium
Minimum Order Quantity: 4

10 Tablets in a Strip

Renodapt-S 360 Tablet is made of Mycophenolate Sodium is an immunosuppressant primarily used to prevent organ rejection in transplant recipients. It reduces the activity of the immune system so that the immune system does not attack the transplanted organ.

Product Description

Renodapt-S 360 Tablet is made of Mycophenolate Sodium is an immunosuppressant primarily used to prevent organ rejection in transplant recipients. It reduces the activity of the immune system so that the immune system does not attack the transplanted organ.


Uses of Renodapt-S 360 Tablet:

  • Prevention of Organ Rejection

How does Renodapt-S 360 Tablet work?

Mycophenolate sodium works by blocking an enzyme that is needed for the growth of lymphocytes, which are immune cells that attack foreign tissue. Mycophenolate inhibits the immunological responses by reducing the production of lymphocytes thereby preventing rejection of the transplanted organ by the body.


How to Use & Dosage

The usual dose for kidney transplant recipients is 720 mg twice daily, but this may vary depending on the specific organ transplant and the patient’s needs. taken by mouth, unless directed otherwise by a healthcare professional, preferably on an empty stomach for best absorption.

Your chemist will give you a Medication Guide to read before you start taking mycophenolate and each time you get a refill. Ask your doctor or chemist any questions you have.

This medication is usually taken by mouth twice a day before meals on an empty stomach (an hour before or two hours after meals), or as directed by your doctor.

Take medicine as a whole. Do not chew or crush. Do not open the capsules if you take them before swallowing.

Your dose is based on your medical condition and response to treatment. And the dose is also affected by the size of the child’s body.

For best results, use this drug every day. Take it daily at the same time to help memory.


Possible Side Effects:

  • Diarrhea
  • Nausea
  • Vomiting
  • Abdominal pain
  • Leukopenia (low white blood cell count)
  • Anemia
  • Headache
  • Dizziness
  • Fatigue

Safety Advise:

🫘 Kidney

Renodapt should be used with caution in patients with renal impairment as it may cause other kidney related problems. Please speak with your healthcare provider.

🟤 Liver

Renodapt may cause other liver related problems. So, patients with a history of liver disease should use it cautiously. Please consult with your healthcare provider.

🤰 Pregnancy

Renodapt 360mg Tablet is not recommended for use during pregnancy as it may be harmful to the fetus. Please speak with your healthcare provider.

🤱 Breastfeeding

We don’t know whether the 360mg Renodapt tablet passes into your breast milk or whether it would harm your baby. If you take this medication ask your doctor how best to give your child nutrition.

🍷 Alcohol

It is recommended that you avoid alcohol consumption while you are taking Renodapt 360 Tablet to prevent any unwanted side effects. Please discuss with your healthcare professional.

🚗 Driving

Renodapt 360 Tablet makes you feel sleepy and faint. Don’t drive or operate machinery when you take it. Please consult your doctor.


Storage Instructions:

Recommended Storage Temperature: 20°C to 25°C (68°F to 77°F). Store container tightly closed and protected from moisture and light.


References

Salvadori M, Holzer H, De Mattos A, Sollinger H, Arns W, Oppenheimer F, Maca J, Hall M; ERL B301 Study Groups. Enteric-Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novo Renal Transplant Patients. American Journal of Transplantation. 2004;4(2):231-236.

Budde K, Curtis J, Knoll G, et al. Enteric-Coated Mycophenolate Sodium can be Safely Administered in Maintenance Renal Transplant Patients: Results of a 1-Year Study. American Journal of Transplantation. 2004;4(2):237-243.

Brunton LL, Knollmann BC, eds. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 14th ed. New York: McGraw-Hill Education.

Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi: Jaypee Brothers Medical Publishers.

Novartis Pharmaceuticals Corporation. Myfortic (mycophenolic acid) Delayed-Release Tablets: Highlights of Prescribing Information. U.S. Food and Drug Administration.


Disclaimer:

IHS Enterprises’s primary objective is to guarantee the accuracy, reliability, and specialist review of the information it provides to customers. The contents and information provided on this website are for informational purposes only. They should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician for guidance and any questions you may have about any condition or medication. If you do read anything from IHS Enterprises, please do not discount or delay in seeking competent medical advice. We want to enhance the doctor-patient relationship, not substitute it.